



Multiple sclerosis (MS) is characterized by lesions in the central nervous system 
(CNS) consisting of dying mature oligodendrocytes, inflammatory response by immune 
cells, and subsequent demyelination of axons. Macrophages and other glial cells are 
essential in response to demyelination, but their role in the remyelination process is only 
partly known. Previous literature suggests a correlation between CNS remyelination and 
macrophage appearance at the site of damage. Here, the function of Proline-rich tyro-
sine kinase 2 (Pyk2), a risk factor tied to neurological diseases including Alzheimer’s 
and Parkinson’s, is explored in macrophages and oligodendrocyte precursor cells in 
terms of MS. Our LFB-PAS histological stainings showed that the initial level of remye-
lination in pyk2-/- mice was significantly higher than that in wild-type mice under cu-
prizone administration, suggesting Pyk2 has an inhibitory effect on remyelination. In ad-
dition, we demonstrated Pyk2 as an important mediator for phagocytosis and signal 
transduction pathway in macrophage activation. Finally, secretome analysis identified 
neutrophilic granule protein (Ngp) being suppressed by Pyk2 in post-phagocytosis mac-
rophages, which was further confirmed by Western blots and immunostaining results. 
Previous report suggests Ngp may subsequently inhibit Cathepsin B (Ctsb), which is 
thought to be elevated in various types of neurological diseases. By understanding the 
cellular function of Pyk2 and downstream expression of Ngp and its regulatory path-






The majority of cells that make up the central nervous system (CNS) are neu-
roglial cells, which assist neurons to function properly. Among glial cells, oligodendro-
cytes are responsible for myelination which insulates the neuronal axons and enhances 
their action potential transduction efficiency. Myelination starts postnatally and contin-
ues into adulthood in both mice and human (Snaidero & Simons, 2014). At times, mye-
lination can be impaired due to external insults and inflammation. In response to demye-
lination, the CNS activates an endogenous repair process including neuroinflammation, 
remyelination, and neuroprotection (Karamita et al., 2017). Oligodendrocyte precursor 
cells (OPCs), originated from the subventricular zone, will migrate to damaged sites 
where they replace dying oligodendrocytes and remyelinate axons (Menn et al., 2006).  
In patients with demyelinating diseases such as Multiple sclerosis (MS), it is be-
lieved that such a reparative mechanism deteriorates. Chronic demyelination in MS 
eventually results in inefficient signal transduction along the axons, eliciting symptoms 
including weakness, paralysis, and dizziness (Ghasemi et al., 2017). The fundamental 
cause of MS is unclear, but studies have attributed MS pathogenesis to activation and 
intrusion of immune cells (mainly B and T lymphocytes), death of oligodendrocytes, and 
axonal interference (Karamita et al., 2017). B cells were considered to produce proin-
flammatory cytokines and autoantibodies targeting myelin basic protein, while T cells 
produce cytotoxic mediators and activate microglia and astrocytes (Jones et al., 2017). 
Current treatments of MS mainly focus on suppressing immune responses, thereby re-
ducing the number of relapses (Gholamzad et al., 2019); however, such therapies have 
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no effect on the accumulation of loss of function in progressive MS due to failure of ad-
equate OPC recruitment and differentiation (Kotter et al., 2005; Sim et al., 2002).  
Macrophages/microglia were previously believed to be a part of the autoimmune 
attack in MS, but recent evidence established their importance in remyelination. Prior to 
remyelination, macrophages/microglia are recruited to site of lesion to initiate debris 
clearance (Matsushima & Morell, 2001). This is an essential step because myelin debris 
not only inhibits axonal growth but also impairs subsequent OPC differentiation (Dubois-
Dalcq et al., 2005; Kotter et al., 2006; Lampron et al., 2015). As proper debris clearance 
progresses, macrophages/microglia usher incoming OPCs to differentiate, eventually 
re-ensheathing damaged axons (Mason et al., 2000). More specifically, recent studies 
have shown that macrophages/microglia promote OPC differentiation via secretion of 
factors which includes tumor necrosis factor alpha (TNF-α), insulin-like growth factor-1 
(IGF-1), and activin-A (Arnett et al., 2001; Hsieh et al., 2004; Kotter et al., 2005; Miron 
et al., 2013). In parallel, our previous unpublished data corroborated that OPC differen-
tiation is directly mediated by factors secreted by macrophages that have engulfed 
apoptotic cells. Given their role in OPC differentiation, macrophages/microglia therefore 
provide us a plausible approach to enhance remyelination through targeted therapeutic 
intervention of their secreted factors.  
The focus of this study is to explore how proline-rich tyrosine kinase 2 (Pyk2) 
regulate activities of macrophages/microglia and OPCs in the context of MS. Pyk2, a 
non-receptor cytoplasmic tyrosine kinase, is known to regulate macrophage processes 
including motility, differentiation, and bacterial phagocytosis (Paone et al., 2016; UniProt 
Consortium, 2019). Studies have reported Pyk2 as a risk factor of Alzheimer’s disease 
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and have linked Pyk2 neuropathologically to Parkinson’s disease (Lambert et al., 2013; 
Takahashi et al., 2003). However, Pyk2’s role in MS pathogenesis has not been previ-
ously reported. An RNA-Seq study on resting state murine CNS mapped Pyk2’s ex-
pression predominantly in microglia and to a lesser extend in oligodendrocytes and 
OPCs (Zhang et al., 2014), which led us to speculate Pyk2 may play an important role 
in macrophages/microglia regulating debris clearance and downstream secretion of fac-
tors. To simulate debris clearance process, apoptotic cells (ACs) were used as stimula-
tion for macrophages in this study. Cellular responses caused by ACs are under-
explored compared to those of myelin debris, and we believe clearance of ACs is just as 
critical as myelin clearance prior to remyelination.  
Cuprizone model was used in this study. A neurotoxicant, cuprizone mimics the 
demyelination and remyelination pattern without activating B or T cells, thereby allowing 
us to study solely the interactions among macrophage/microglia and glial cells 
(Matsushima & Morell, 2001). During the study, we observed an accelerated remye-
lination in pyk2-/- mice compared to wild-type through LFB/PAS histology. Next, we no-
ticed that deficiency of Pyk2 dramatically impaired phagocytosis of ACs in macrophages. 
A parallel phosphoproteomics study (data not shown) on macrophages’ phagocytosis of 
ACs revealed phosphorylation of an under-examined site (S747) on Pyk2, and we have 
generated point-mutated pyk2 constructs for future testing of this site. To investigate 
targets in pyk2-/- mice that caused accelerated remyelination, we conducted a secre-
tome analysis on post-phagocytosis wild-type and pyk2-/- macrophages and identified 
neutrophilic granule protein (Ngp) as one potential protein normally suppressed by Pyk2. 
We speculated Ngp is an important mediator of OPC differentiation, and subsequently 
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corroborated its upregulation in pyk2-/- macrophages through immunocytostainings and 
Western blots. In conclusion, we have not only uncovered a list of secreted factors that 
potentially contribute to acceleration of remyelination, but also hypothesized a model 
explaining how macrophages/microglia regulate OPCs and subsequent remyelination 
through a pathway involving Ngp. Such a model has exciting potentials, as Ngp may 
prove to be a useful therapeutic target to improve or accelerate remyelination and 
thereby curing MS.  
 
Materials and Methods 
Reagents and Resources Source Catalog Number 
3% Thioglycollate yeast extract Matsushima Lab 
 
Dexamethasone (DEX) Sigma-Aldrich D4902 
Paraformaldehyde (PFA) Sigma-Aldrich P6148 
Schiff's fuchsin-sulfite reagent Sigma-Aldrich S5133 
Hematoxylin Stain Solution, Gill 3 Ricca 3537-32 
Solvent blue 38 Sigma-Aldrich S-3382 
Permount Mounting Medium Thermo Fisher Scientific SP15-100 
CellTracker Green CMFDA Dye Thermo Fisher Scientific C2925 
CellTracker Orange CMTMR Dye Thermo Fisher Scientific C2927 
RMPI 1640 Media Thermo Fisher Scientific 11875-093 
RMPI 1640 Media no phenol red Thermo Fisher Scientific 11835-030 
Fetal Bovine Serum (FBS) Gemini 100-106 
VECTASHIELD Hardset Mounting Medium Vector Lab H-1500 
3xFLAG/Pyk2 Construct VectorBuilder 
 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich D2650 
QIAprep Miniprep kit  Qiagen 27104 
QuikChange Mutagenesis kit Agilent 200515 
FuGENE 6 Promega E269A 
VIVASPIN 6 300,000 kDa filters Sartorius VS0652 
Amicon Ultra 3,000 kDa filters Millipore UFC500324 
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Reagents and Resources Source Catalog Number 
α-NGP antibody (Rabbit) Rockland 600-401-GW9S 
α-Rabbit IgG Alexa Fluor 488 Invitrogen A21206 
α-Rabbit IgG HRP Vector Lab PI-1000 
PageRuler Plus Prestained Protein Ladder Thermo Fisher Scientific 26619 
ECL Western Blotting Detection Reagent Amersham RPN2232 
Protease Inhibitor Cocktail Sigma-Aldrich P8340 
PhosStop Roche 4906845001 
   
 
Mice and cuprizone administration 
C57BL/6J (wild-type) mice were purchased from the Jackson Laboratory. pyk2-/- 
mice were a gift from Dr. Michael Schaller (West Virginia University, Morgantown, WV) 
and were maintained on a C57BL/6J background. All mice were bred and handled un-
der pathogen free conditions by the Matsushima Lab under the protocols approved by 
the University of North Carolina at Chapel Hill Institutional Animal Care and Use Com-
mittee (IACUC).  
Cuprizone administration has been previously described (Hiremath et al., 1998). 
Briefly, 8-10 weeks old mice were fed with a 0.2% w/w cuprizone-containing diet or a 
control diet for 5 weeks, and subsequently were given control diets ad libitum for a dura-
tion ranging from 0 to 3 weeks for remyelination. Mice were perfused with phosphate 
Mutagenesis Primers   
Sequence (5' --> 3') Identifier Source 
AGCATAGAGTCAGACATCTTTGCGGAGATTCCCGATGAGACC Y402F Eurofins Scientific 
AATGTGGCCGTCGCCACCTGTAAGAAAGACTGTA K457A Eurofins Scientific 
CATTGAGGACGAAGACTTTTTCAAAGCCTCTGTGACCCGTC Y579F/Y580F Eurofins Scientific 
TCTGTGTGCCAGCGCACCTACGCTTA S747A Eurofins Scientific 




buffer containing 4% paraformaldehyde (PFA) and brain samples were harvested and 
coronally sectioned at 5µm. Both male and female mice were used in the experiments 
since no obvious difference between sexes under cuprizone administration was previ-
ously observed (Taylor et al., 2010). 
 
Luxol fast blue/periodic acid Schiff (LFB-PAS) staining 
LFB-PAS stainings were performed as previously described (Arnett et al., 2002). 
Briefly, 4% PFA-fixed 5µm coronal brain sections on slides were dehydrated, incubated 
overnight at 60°C in 0.2% Solvent Blue 38 and dipped in 70% ethanol to wash off ex-
cessive stainings. Sections were then stained with Periodic acid-Schiff (PAS) and Gill 3 
hematoxylin. Slides were then dehydrated and mounted in Permount. LFB-PAS stained 
slides were then graded in a double-blind fashion, and the level of myelination was rat-
ed on a three-point scale, with higher scores representing better myelination.  
  
Preparation of macrophages 
Thioglycollate-elicited macrophages were obtained as previously described 
(Scott et al., 2001). Briefly, 8-12 weeks old mice were intraperitoneally injected with 3 
mL of 3% thioglycolate prior to harvest by peritoneal wash in Versene. Peritoneal exu-
date cells (PECs) were washed 3 times in PBS prior to resuspension in RPMI with 5% 
FBS. For phagocytosis assays of apoptotic cells (ACs), PECs were plated on Poly-D-
Lysine coated coverslips in 24-well plates at a density of 1.5 x 105 cells/well. For lysate 
and supernatant collection purposes, PECs were plated in 100 mm dishes at a density 
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of 1x107 cells/dish. PECs were allowed to adhere overnight at 37 ºC 5% CO2 and were 
subsequently washed to retained only macrophages.  
 
Inducing apoptotic cells 
ACs were harvested as previously described (Seitz et al., 2007). Briefly, thymi 
from 4-6 weeks old wild-type mice were harvested and tissues were mechanically dis-
sociated using forceps. Cells were then washed and incubated in RPMI 1640 media 
with 5% FBS containing 2µM dexamethasone (DEX) at a density of 5 x 106 cells/mL in a 
37 ºC water bath for 4 hours. During the incubation, a gentle agitation was performed 
every hour to ensure even distribution of DEX. For imaging phagocytosis, ACs were 
washed with PBS to remove DEX and were stained with 2µM CellTracker Green after 
2.5 hours of incubation prior to resuspension in RPMI 1640 with 5% FBS. For collecting 
macrophage lysates and supernatants, ACs were washed with PBS to remove DEX af-
ter 3.5 hours of incubation prior to resuspension in RPMI 1640 with 5% FBS.   
  
Phagocytosis of apoptotic cells 
24-hour post-plating macrophages were stained with CellTracker Orange prior to 
ACs stimulation at a 10:1 ratio of AC: macrophage. After 30 minutes of macrophage 
stimulation at 37 ºC, wells were washed repeatedly with PBS until no free-floating ACs 
were observed. Cells were then fixed with 1% PFA for 15 minutes, and the coverslips 
were placed onto microscope slides with Vectashield. Immunostainings were viewed 
with ZEN software on Zeiss LSM 780 confocal microscope to obtain z-stack images. 
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Macrophages were then counted to determine the percentage of phagocytosis based on 
whether their fluorescent signals overlap with those of ACs (procedural flowchart in Fig-
ure 1).  
 
Cloning and directed mutagenesis 
3xFLAG/murine Pyk2 construct was purchased from VectorBuilder. Constructs encod-
ing various point mutations on pyk2 were generated by QuikChange site-directed muta-
genesis kit. Briefly, 3xFLAG/Pyk2 wild-type plasmids were extracted using Maxiprep kit 
and were amplified in PCR according to manufacturer’s protocol. Samples were then 
sequenced (Eton Bioscience) to ensure successful mutagenesis prior to amplification in 
bacteria. Constructs containing mutated Pyk2 were collected using miniprep and stored 
at -20 ºC for future use.  
 
Supernatant collection of activated macrophages 
Figure 1. Flowchart of the phagocytosis of apoptotic cells assay procedure.    
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24-hour post-plating macrophages were stimulated by ACs at a 10:1 ratio of AC: 
macrophage. After 30 minutes of macrophage stimulation at 37 ºC, dishes were washed 
repeatedly with PBS until no free-floating ACs were observed. Macrophages were incu-
bated in RPMI phenol-free media overnight at 37 ºC prior to supernatant collection, and 
supernatants were subsequently concentrated using VIVASPIN 6 and Amicon Ultra fil-
ters following manufacturers’ protocols. Samples were then prepared and analyzed by 
the UNC Proteomics Core Facility. 
  
Sample preparation for LC-MS/MS analysis 
The concentrated supernatants were denatured with 7M urea, reduced with 5mM 
DTT for 30 minutes at 37°C, then alkylated using 15 mM iodoacetamide for 30 min at 
room temperature. Each sample was then diluted to 0.5M Urea with 50 mM ammonium 
bicarbonate and digested with trypsin (1:50) overnight at 37°C. Digestion was quenched 
by acidifying to pH <2 and desalted using Thermo Pierce C18 spin columns. Peptides 
were quantified using the Pierce Colorimetric Peptide Quantitation Kit. 
  
LC-MS/MS analysis and data processing 
Samples (1 µg) were analyzed by LC-MS/MS using a Thermo Easy nLC 1200 
coupled to an Orbitrap QExactive HF mass spectrometer equipped with an EasySpray 
nano source. Samples were loaded onto an EasySpray C18 column (75 µm ID X 25cm, 
2 µm particle size) and eluted over a 90 min method. The gradient for separation con-
sisted 5-40% B at a 250 nl/min flow rate, where mobile phase A [water, 0.1% formic ac-
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id] and mobile phase B [80% acetonitrile, 0.1% formic acid]. The QExactive HF was op-
erated in data-dependent mode where the 15 most intense precursors were selected for 
subsequent fragmentation. Resolution for the precursor scan (m/z 350–1700) was set to 
60,000 with a target value of 3 × 106 ions, 100 ms max IT. MS/MS scans resolution was 
set to 15,000 with a target value of 1 × 105 ions, 60 ms max IT. The normalized collision 
energy was set to 27% for HCD. Dynamic exclusion was set to 30 s and precursors with 
unknown charge or a charge state of 1 and ≥ 7 were excluded. 
 Raw data were processed using the MaxQuant software suite (version 1.6.1.0) 
for protein identification and label-free quantitation (Cox & Mann, 2008; Cox et al., 2011). 
Data were searched against a Uniprot mouse database using the integrated Andromeda 
search engine. A maximum of two missed tryptic cleavages were allowed. The fixed 
modification specified was carbamidomethylation of cysteine residues and the variable 
modification specified was oxidation of methionine. Match between runs was enabled. 
Results were filtered to 1% FDR at the unique peptide level and grouped into proteins 
within MaxQuant (Cox et al., 2014). Only proteins with >1 unique+razor peptide were 
used for label-free quantitation. Statistical analyses (ANOVA, Student’s t-test) were per-
formed in Perseus software. 
  
Immunocytochemistry 
Macrophages on coverslips were fixed with 1% PFA for 15 minutes. After block-
ing with 5% milk, samples were incubated with α-Ngp antibody (1:200) for 1 hour at 
room temperature. Proteins were then visualized with α-Rabbit IgG Alexa Fluor 488 
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(1:1000) and placed onto microscope slides with Vectashield. Immunofluorescence 
stainings were captured with ZEN software on Zeiss LSM 780 confocal microscope and 
quantified using ImageJ.  
  
Western blots 
Cell lysates were prepared in lysis buffer consist of 0.1% NP-40, 50mM Tris-HCl 
(pH = 8), 150mM NaCl, 2mM EDTA, 1,10-phenanthroline, and 2x protease inhibitor 
cocktail (Sigma). 25 ug of lysate samples were separated on 10% SDS-PAGE gel and 
transferred to nitrocellulose membranes. After blocking with 5% milk, membranes were 
washed and incubated with α-Ngp antibody (1:1000) overnight at 4°C. Proteins were 
then detected with α-Rabbit IgG HRP (1:10000) and visualized using ECL kit. Western 
blot images were subsequently captured with Amersham Imager 600 and quantified us-
ing ImageJ.  
 
Statistical analysis 
Data are expressed as mean ± SE. Statistical analysis of different groups was 
performed by Student’s test as indicated. P < 0.05 was considered significant. All statis-







Pyk2-Deficient Mice Demonstrate Accelerated Remyelination 
To determine the effect of Pyk2 in cuprizone-induced demyelination of corpus 
callosum, pyk2-/- and wild-type mice were fed 0.2% w/w cuprizone diet for 5 wk, and 
corpus callosum sections over a time course were collected and stained with LFB/PAS 
(representative stainings in Figure 2A). Myelination levels were quantified in a double-
blind fashion. By 5 wk, sections of both pyk2-/- and wild-type mice showed almost full 
demyelination, as indicated by the scores near zero (Figure 2B). However, myelination 
levels ensued with the subsequent removal of cuprizone were significantly (p < 0.05) 
greater in the pyk2-/- mice (1.57 ± 0.26) compared to wild-type mice (0.74 ± 0.19) treat-
ed at 5+1 wk (Figure 2B). The results demonstrate that the deficiency of Pyk2 causes 




Figure 2. pyk2-/- mice show accelerated remyelination compared with wild-type 
mice in the corpus callosum after cuprizone treatment. A, LFB-PAS stained cor-
onal brain sections of corpus callosum from WT and pyk2-/-
 
mice at 5+1 wk. Corpus 
callosum areas were indicated in red. Scale bar = 100 µm. B, quantification of the 
myelination levels in corpus callosum. Stained sections were assessed in a double-
blind fashion, and the levels of myelination were rated on a three-point scale. Higher 
scores represent greater levels of myelination. pyk2-/-
 
mice show statistically signifi-
cant increases in remyelination at 5+1 (p < 0.05) and 5+3 wk (p < 0.01) by Student's 
t-test. n ≥ 6 for all treatment groups. UT = untreated.  
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Pyk2 is Required for Phagocytosis of Apoptotic Cells by Macrophages 
To assess Pyk2’s role, pyk2-/- and wild-type macrophages were stimulated with 
ACs to trigger phagocytosis. Macrophages and ACs were labeled with different fluores-
cent tags, and the quantification of the percentages of macrophages (orange) that in-
gested ACs (green) was based on the overlapping of their respective fluorescent signal 
(representative images in Figure 3A; schematic drawing in Figure 3B). In absence of 
Pyk2, a significant impairment (p < 0.01) in macrophages’ ability to ingest ACs was ob-
served (10.4 ± 0.9%) compared to that in wild-type (26.7 ± 1.5%) (Figure 3C). The re-




Pyk2 Mutant Variant Constructs 
S747 on Pyk2, an under-examined phosphorylation site, was phosphorylated in 
macrophages during phagocytosis of ACs in a parallel phosphoproteomics study (data 
not shown). Since we proved Pyk2’s regulation of macrophage phagocytosis of ACs, we 
speculated that S747 on Pyk2 is responsible for phagocytosis’ downstream signaling 
events leading to secretion of factors that affect OPC differentiation. To address this 
question, we have purchased a construct containing pyk2 gene (Figure 4) and S747A 
mutagenesis primer to generate S747A pyk2 construct. In addition, mutagenesis pri-
mers targeting sites (Y402F, K457A, and Y579F/Y580F) responsible for Pyk2’s kinase 
activity were purchased to test whether the secretion of differentiation factors is inde-
pendent of Pyk2’s kinase activity. We have generated several mutant variants of pyk2 
so far, including S747A and Y402/Y579F/Y580F. The ongoing next step is to transfect a 
murine microglial cell line, BV-2. For negative control, lentiviral pyk2 shRNA clones 
were obtained from the UNC Lenti-shRNA Core Facility and will be used on BV-2. The 
resulting stable BV-2 clones with different variants of Pyk2 expressions will allow us to 
Figure 3. pyk2 is an important mediator of phagocytosis of apoptotic cells by 
macrophages. A, Confocal images of phagocytosis of ACs (10:1 ACs to macro-
phages) by wild-type (WT) and pyk2-/- macrophages. Macrophages were labeled or-
ange, ACs were labeled green, and cell nuclei were labeled blue with DAPI. Z-stack 
images were acquired using Zeiss LSM 780 confocal microscope. Scale bar = 100 
µm. B, visual representation of overlapping of fluorescent signals during phagocyto-
sis in 3A. Colors correspond to those in 3A. C, quantification of ingestion of ACs by 
WT and pyk2-/- macrophages. At least 250 macrophages of each replicate were 
counted. n = 4. **p < 0.01, Student’s t-test.  
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assess what phosphorylation sites on Pyk2 are responsible for phagocytosis and for se-
cretion of factors post-phagocytosis in a murine cell line.  
 
 
Figure 4. wild-type pyk2 gene construct. A construct containing murine pyk2 
(mPtk2b). pyk2 fused with 3xFLAG gene for visualization and immunoprecipitation 
purposes. Hygromycin resistance gene was incorporated for antibiotic selection pur-
pose. Targeted phosphorylation sites were labeled on the construct in green, con-
tained in regions of mutagenesis primers in red.   
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Secretome Analysis of Macrophages Stimulated by Apoptotic Cells 
 Unpublished data from previous lab members has shown that macrophages pro-
vide OPCs with extracellular factors that induce activation, growth, and differentiation. 
Since in vivo LFB-PAS histology has demonstrated that the deficiency of Pyk2 resulted 
in faster remyelination, factors secreted in pyk2-/- macrophages were speculated to 
stimulate OPC proliferation and differentiation. Here, the secreted factors from post-
phagocytosis pyk2-/- and wild-type macrophages were identified and analyzed by the 
UNC Proteomics Core Facility (procedural flowchart shown in Figure 5A). Out of the 
1,000 proteins filtered and quantified, Student’s t-test (p < 0.05) resulted in 37 statistical-




Figure 5. Secretome profile of post-phagocytosis Macrophages reveals poten-
tial mediators of phagocytosis. Supernatants of wild-type (WT) and pyk2-/- macro-
phages were collected 24 hr post-phagocytosis of ACs and were analyzed by the 
UNC Proteomics Core Facility. A, proteomics workflow. Samples were digested and 
enriched prior to LC/MS/MS analysis. Proteins were then identified and quantified us-
ing MaxQuant software. Heatmap was subsequently generated using Perseus. B, 
heatmap of secreted proteins in WT (B6) and pyk2-/-
 
macrophages. Student’s t-test 
revealed 37 proteins that showed significantly different expression levels between 
WT and pyk2-/- secretome profiles (Red = high; Blue = low). Proteins were catego-
rized under two clusters by their generic functions.  
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Secreted proteins were categorized into two clusters based on their respective 
expression levels represented by LFQ intensities. Cluster 1 represents secreted pro-
teins upregulated in pyk2-/- macrophages responsible mainly for RNA binding, while 
cluster 2 represents those upregulated in wild-type macrophages responsible for cell 
adhesion. Among the secreted factors upregulated in pyk2-/- macrophages, neutrophilic 
granule protein (Ngp), a cysteine-type endopeptidase, was identified to be the top can-
didate, showing a 7.30-fold upregulation compared to its level in wild-type macrophages 
(Table 1). The significant upregulation of Ngp suggests itself a strong candidate for ac-
celerated remyelination in pyk2-/- mice.  
Table 1. Top 5 protein candidates upregulated in 24 hr post-phagocytosis wild-
type and pyk2-/-
 
macrophages. Refer to Figure 5. Label-free quantification (LFQ) 
intensity of proteins were obtained using MaxQuant, and the LFQ ratios of proteins in 
wild-type and pyk2-/- macrophages were subsequently calculated. Top 5 most upregu-





Pyk2 Regulates Ngp Expression in Macrophages 
 To investigate further, a time course study of Ngp expression in pyk2-/- and wild-
type macrophages was performed to corroborate the secretome findings and to deter-
mine the time point where Ngp is upregulated in absence of Pyk2. Macrophages 6 and 
18 hr after ACs stimulation were assessed by immunocytochemistry and Western blot.  
For immunostaining, macrophages were fixed with 1% PFA and immunostained 
for Ngp (Green) prior to image capture. Levels of Ngp expression present in wild-type 
and pyk2-/- macrophages post-phagocytosis were subsequently quantified by integrated 
density.  A decrease of Ngp level in wild-type and an increase of Ngp level in absence 
of Pyk2 were observed compared to their respective controls in 18 hr post-phagocytosis 
macrophages (Figure 6A, B). No visual difference was observed in 6 hr post-
phagocytosis macrophages (Figure not shown). We speculate the resemblance of Ngp 
level at 6 hr was due to insufficient time of Ngp transcription and translation.  
For Western blot, macrophage lysates were harvested and ran on a 10% SDS-
PAGE gel. Ngp levels of all samples were subsequently detected and normalized to 
their respective β-actin levels prior to normalization to the Ngp level of WT control. By 
18 hr post-phagocytosis, intracellular level of Ngp was suppressed in wild-type macro-
phages to half-fold but elevated in pyk2-/- macrophages to 2-fold (Figure 6C, D). In con-
clusion, immunostaining and Western blot results demonstrated the elevation of Ngp 
production in pyk2-/- macrophages compared to wild-type macrophages, validating the 








 We have demonstrated in this study that AC-induced macrophage activation 
pathway is Pyk2-mediated. This is important in the context of MS, as Pyk2 is now tied to 
a necessary process during MS pathogenesis, providing us a new perspective. On the 
other hand, the complete depletion of Pyk2 leads to accelerated remyelination in the 
murine CNS, possibly through regulating secretion of Ngp and suppressing other factors 
detrimental to OPC differentiation.  
We suspect that the dual roles of Pyk2 in phagocytosis and secreting of factors 
are partly due to Pyk2 expression in OPCs, which was not addressed in this study. As 
stated earlier, an RNA-Seq study showed that Pyk2 is expressed in OPCs in a resting 
murine brain (Zhang et al., 2014); however, Pyk2’s protein expression levels among the 
glial cells have yet to be established, especially in the context of MS. Our immediate 
next step is therefore to conduct an immunohistostaining, colocalizing Pyk2 with micro-
glia and OPCs respectively at 5+1 wk of cuprizone in wild-type mice. The result will give 
us a more direct view of whether Pyk2 has a bigger role in OPCs themselves during MS 
pathogenesis.  
Figure 6. Pyk2 regulates level of Ngp in post-phagocytotic macrophages. Wild-
type (WT) and pyk2-/-
 
macrophages were stimulated with ACs prior to experiments. A, 
immunostaining of Ngp in WT and pyk2-/-
 
macrophages 18hr post ACs stimulation. 
Cells were fixed with 1% PFA for 15 mins prior to staining. Green = Ngp, and blue = 
DAPI. Scale bar = 20 µm. B, quantification of intracellular Ngp fluorescence. Fluores-
cence intensities normalized to that of WT control. C, Western blot of Ngp in lysates 
from WT and pyk2-/-
 
macrophages 6 and 18 hr post ACs stimulation. Controls did not 
receive stimulation and were collected at 6 hr time point. D, quantification of intracel-
lular level of Ngp in lysates. Ngp levels were normalized to β-actin levels, followed by 
normalization to WT control. A decrease in Ngp level in WT macrophages and an in-
crease in pyk2-/-
 
macrophages were observed in both 6B and 6D.   
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 The phosphoproteomics study demonstrated that phosphorylation of S747 on 
Pyk2 is significantly impeded during phagocytosis when a major phagocytosis receptor 
is knocked out from macrophages (data not shown). S747 of Pyk2 has been previously 
implicated as part of the nuclear targeting sequence of Pyk2, which assists in nuclear 
localization (Faure et al., 2013). We speculate that the internalization of apoptotic cells 
during phagocytosis inhibits transcription of factors for OPC differentiation that is medi-
ated briefly by Pyk2. Combined with the fact that pyk2-/- mice demonstrated accelerated 
remyelination, a potential key link where Pyk2 may inhibit remyelination lies in its ability 
to regulate phosphatases and subsequent downstream signal transduction. Thus, the 
position of Pyk2 in regulating signal transduction and reparative pathways warrants fur-
ther investigation. We have already generated plasmids with mutant Pyk2 variants, and 
we will transfect murine microglial BV-2 cells to test whether S747 is responsible for 
regulating secretion of factors beneficial to OPC differentiation.  
 After literature searches on factors identified in secretome analysis, we believe 
Ngp could be a likely therapeutic target for MS. Ngp was reported as a cathepsin B 
(Ctsb) inhibitor (Boutté et al., 2011), which is a lysosomal cysteine protease necessary 
in immune response and cell turnover (Mort & Buttle, 1997). Specifically, increased lev-
els of Ctsb activity were observed in brains and peripheral blood macrophages of MS 
patients (Bever & Garver, 1995; Bever et al., 1994).  Furthermore, the literature sug-
gested cysteine proteases could serve as therapeutic targets for neurological diseases 
including Alzheimer’s, multiple sclerosis, and brain traumatic injuries (Haves-Zburof et 
al., 2011; Hook et al., 2015; Siklos et al., 2015). In addition, Pyk2 deficiency leads to in-
efficient neutrophil degranulation (Kamen et al., 2011). The findings further validate our 
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speculation that the absence of Pyk2 would permit Ngp to ameliorate the proteolytic ac-
tivities in the extracellular environment. To support our point, we will need to quantify 
the amount of Ngp and Ctsb as well as colocalizing these proteins with microglia during 
our cuprizone administration time course.  
 Aside from Ngp, other upregulated protein candidates in Pyk2-/- macrophages 
were also inspected. Shmt1 is a cellular response to leukemia inhibitory factor (LIF), 
which is an IL-6 cytokine that induces cell differentiation; Serpinf1 induces extensive 
neuronal differentiation and inhibits endopeptidase activity; and Acp5 inhibits inflamma-
tory response by negatively regulating IL-12 and IL-1β production (Uniprot Consortium, 
2019). Thus, these other secreted factors by pyk2-/- secretome may augment the repar-
ative process.  We observed that even though these proteins have not been upregulat-
ed as much as Ngp had, they uniformly exhibit functions including cell differentiation 
and anti-inflammation; therefore, these proteins are also worth studying in the future.  
 Taken collectively, we have proposed a model describing interaction between 
macrophages/microglia and OPCs during remyelination through Pyk2 and Ngp (Figure 
7). Upon macrophages binding and phagocytizing apoptotic cells, Pyk2 becomes phos-
phorylated at S747 and migrates inside the nucleus of activated macrophages. pPyk2 
inhibits the transcription of Ngp as well as other potential differentiation factors through 
an unknown mechanism, indirectly allowing for Ctsb proteolytic activities in area of le-
sion and delaying remyelination; however, in absence of Pyk2 phosphorylation of S747, 
phagocytosis proceeds normally in macrophages, but Pyk2 no longer translocate to the 
nucleus. Transcription of Ngp and differentiation factors are no longer suppressed, and 
Ngp is secreted to inactivate Ctsb released by own macrophage and other neighbors 
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while differentiation factors are given to OPC to instruct differentiation. Such a model is 
still rudimentary and requires extensive testing. As we address questions within the 
model, an important issue remains unresolved and require further study.  For example, 
what is Pyk2’s involvement in phagocytosis of myelin-stimulated macrophages. Lastly, 
Pyk2 may have dual roles in macrophages where we will need to stimulate macrophag-
es with both ACs and myelin as this condition will more accurately reflect the events 
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